Article
Vaccine of engineered tumor cells secreting stromal cell-derived factor-1 induces T-cell dependent antitumor responses.
Cancer biotherapy & radiopharmaceuticals - 1 Aug 2005
Shi Meiqing, Hao Siguo, Su Liping, Zhang Xueshu, Yuan Jinying, Guo Xuling, Zheng Changyu, Xiang Jim
Abstract excerpt
The CXC chemokine SDF-1 has been characterized as a T-cell chemoattractant both in vitro and in vivo. To determine whether SDF-1 expression within tumors can influence tumor growth, we transfected an expression vector pCI-SDF-1 for SDF-1 into J558 myeloma cells and tested their ability to form tumors in BALB/c. Production of biologically active SDF-1 (1.2 ng/mL) was detected in the culture supernatants of cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
